482 related articles for article (PubMed ID: 20019244)
1. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
[TBL] [Abstract][Full Text] [Related]
3. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jul; 36(7):1444-52. PubMed ID: 18385292
[TBL] [Abstract][Full Text] [Related]
5. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
[TBL] [Abstract][Full Text] [Related]
6. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
[TBL] [Abstract][Full Text] [Related]
7. Induction of CYP2C genes in human hepatocytes in primary culture.
Gerbal-Chaloin S; Pascussi JM; Pichard-Garcia L; Daujat M; Waechter F; Fabre JM; Carrère N; Maurel P
Drug Metab Dispos; 2001 Mar; 29(3):242-51. PubMed ID: 11181490
[TBL] [Abstract][Full Text] [Related]
8. Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes.
Schaefer O; Ohtsuki S; Kawakami H; Inoue T; Liehner S; Saito A; Sakamoto A; Ishiguro N; Matsumaru T; Terasaki T; Ebner T
Drug Metab Dispos; 2012 Jan; 40(1):93-103. PubMed ID: 21979928
[TBL] [Abstract][Full Text] [Related]
9. Expressions of cytochrome P450, UDP-glucuronosyltranferase, and transporter genes in monolayer carcinoma cells change in subcutaneous tumors grown as xenografts in immunodeficient nude mice.
Sugawara M; Okamoto K; Kadowaki T; Kusano K; Fukamizu A; Yoshimura T
Drug Metab Dispos; 2010 Mar; 38(3):526-33. PubMed ID: 20007293
[TBL] [Abstract][Full Text] [Related]
10. Functional expression, inhibition and induction of CYP enzymes in HepaRG cells.
Turpeinen M; Tolonen A; Chesne C; Guillouzo A; Uusitalo J; Pelkonen O
Toxicol In Vitro; 2009 Jun; 23(4):748-53. PubMed ID: 19328226
[TBL] [Abstract][Full Text] [Related]
11. Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction.
Hariparsad N; Carr BA; Evers R; Chu X
Drug Metab Dispos; 2008 Jun; 36(6):1046-55. PubMed ID: 18332078
[TBL] [Abstract][Full Text] [Related]
12. Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells.
Lambert CB; Spire C; Claude N; Guillouzo A
Toxicol Appl Pharmacol; 2009 Feb; 234(3):345-60. PubMed ID: 19084549
[TBL] [Abstract][Full Text] [Related]
13. Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix.
Gómez-Lechón MJ; Jover R; Donato T; Ponsoda X; Rodriguez C; Stenzel KG; Klocke R; Paul D; Guillén I; Bort R; Castell JV
J Cell Physiol; 1998 Dec; 177(4):553-62. PubMed ID: 10092208
[TBL] [Abstract][Full Text] [Related]
14. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
[TBL] [Abstract][Full Text] [Related]
16. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes.
Richert L; Tuschl G; Abadie C; Blanchard N; Pekthong D; Mantion G; Weber JC; Mueller SO
Toxicol Appl Pharmacol; 2009 Feb; 235(1):86-96. PubMed ID: 19118567
[TBL] [Abstract][Full Text] [Related]
17. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
Braeuning A; Sanna R; Huelsken J; Schwarz M
Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
[TBL] [Abstract][Full Text] [Related]
18. Liver grafts preserved in Celsior solution as source of hepatocytes for drug metabolism studies: comparison with surgical liver biopsies.
Donato MT; Serralta A; Jiménez N; Pérez G; Castell JV; Mir J; Gómez-Lechón MJ
Drug Metab Dispos; 2005 Jan; 33(1):108-14. PubMed ID: 15448115
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome p450 expression of cultured rat small hepatocytes after long-term cryopreservation.
Ooe H; Kon J; Miyamoto S; Ozone Y; Ninomiya S; Mitaka T
Drug Metab Dispos; 2006 Oct; 34(10):1667-71. PubMed ID: 16868070
[TBL] [Abstract][Full Text] [Related]
20. A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cells.
Klein M; Thomas M; Hofmann U; Seehofer D; Damm G; Zanger UM
Drug Metab Dispos; 2015 Feb; 43(2):273-83. PubMed ID: 25480923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
